JP2019518569A - 内視鏡的剥離術後の食道狭窄を予防するための自己集合性ペプチドマトリックス - Google Patents

内視鏡的剥離術後の食道狭窄を予防するための自己集合性ペプチドマトリックス Download PDF

Info

Publication number
JP2019518569A
JP2019518569A JP2018567639A JP2018567639A JP2019518569A JP 2019518569 A JP2019518569 A JP 2019518569A JP 2018567639 A JP2018567639 A JP 2018567639A JP 2018567639 A JP2018567639 A JP 2018567639A JP 2019518569 A JP2019518569 A JP 2019518569A
Authority
JP
Japan
Prior art keywords
solution
peptide
esophagus
target area
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018567639A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019518569A5 (enExample
Inventor
マリー レヴェイエ−ビュフィエ，
マリー レヴェイエ−ビュフィエ，
ユン ソク ギル，
ユン ソク ギル，
フレデリック プラ，
フレデリック プラ，
マクシミリアン ルイ フランソワ バンジャマン バレ，
マクシミリアン ルイ フランソワ バンジャマン バレ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP filed Critical Assistance Publique Hopitaux de Paris APHP
Publication of JP2019518569A publication Critical patent/JP2019518569A/ja
Publication of JP2019518569A5 publication Critical patent/JP2019518569A5/ja
Priority to JP2021192987A priority Critical patent/JP2022023249A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/267—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the respiratory tract, e.g. laryngoscopes, bronchoscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2018567639A 2016-06-27 2017-06-27 内視鏡的剥離術後の食道狭窄を予防するための自己集合性ペプチドマトリックス Withdrawn JP2019518569A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021192987A JP2022023249A (ja) 2016-06-27 2021-11-29 内視鏡的剥離術後の食道狭窄を予防するための自己集合性ペプチドマトリックス

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662355111P 2016-06-27 2016-06-27
US62/355,111 2016-06-27
PCT/US2017/039407 WO2018005427A1 (en) 2016-06-27 2017-06-27 Self-assembling peptide matrix for the prevention of esophageal stricture after endoscopic dissection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021192987A Division JP2022023249A (ja) 2016-06-27 2021-11-29 内視鏡的剥離術後の食道狭窄を予防するための自己集合性ペプチドマトリックス

Publications (2)

Publication Number Publication Date
JP2019518569A true JP2019518569A (ja) 2019-07-04
JP2019518569A5 JP2019518569A5 (enExample) 2020-07-30

Family

ID=59295359

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018567639A Withdrawn JP2019518569A (ja) 2016-06-27 2017-06-27 内視鏡的剥離術後の食道狭窄を予防するための自己集合性ペプチドマトリックス
JP2021192987A Pending JP2022023249A (ja) 2016-06-27 2021-11-29 内視鏡的剥離術後の食道狭窄を予防するための自己集合性ペプチドマトリックス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021192987A Pending JP2022023249A (ja) 2016-06-27 2021-11-29 内視鏡的剥離術後の食道狭窄を予防するための自己集合性ペプチドマトリックス

Country Status (8)

Country Link
US (1) US20190358290A1 (enExample)
EP (1) EP3474880A1 (enExample)
JP (2) JP2019518569A (enExample)
CN (1) CN109996553A (enExample)
AU (1) AU2017289150A1 (enExample)
BR (1) BR112018077219A2 (enExample)
CA (1) CA3029455A1 (enExample)
WO (1) WO2018005427A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021529024A (ja) * 2018-06-21 2021-10-28 ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 食道粘膜下流体クッションとしての細胞外マトリックス（ｅｃｍ）ヒドロゲルの使用
AU2019288588B2 (en) 2018-06-21 2024-06-13 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Extracellular matrix (ECM) hydrogel as a submucosal fluid cushion
WO2021202577A1 (en) 2020-03-31 2021-10-07 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
RU2751285C1 (ru) * 2020-07-22 2021-07-12 Федеральное государственное бюджетное научное учреждение "Российский научный центр хирургии имени академика Б.В. Петровского" Способ хирургического лечения стриктур пищеводных анастомозов

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007037407A1 (ja) * 2005-09-30 2007-04-05 3-D Matrix Japan, Ltd. 細胞の培養方法および細胞培養物
WO2013133413A1 (ja) * 2012-03-09 2013-09-12 株式会社スリー・ディー・マトリックス 粘膜隆起剤
JP2016515113A (ja) * 2013-03-14 2016-05-26 株式会社スリー・ディー・マトリックス 消化管閉塞の予防のための材料

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050245788A1 (en) * 2004-04-28 2005-11-03 Medtronic, Inc. Esophageal delivery system and method with position indexing
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
CA2939696C (en) * 2014-03-10 2023-01-10 3-D Matrix, Ltd. Self-assembling peptide compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007037407A1 (ja) * 2005-09-30 2007-04-05 3-D Matrix Japan, Ltd. 細胞の培養方法および細胞培養物
WO2013133413A1 (ja) * 2012-03-09 2013-09-12 株式会社スリー・ディー・マトリックス 粘膜隆起剤
JP2016515113A (ja) * 2013-03-14 2016-05-26 株式会社スリー・ディー・マトリックス 消化管閉塞の予防のための材料

Also Published As

Publication number Publication date
JP2022023249A (ja) 2022-02-07
EP3474880A1 (en) 2019-05-01
WO2018005427A1 (en) 2018-01-04
CN109996553A (zh) 2019-07-09
US20190358290A1 (en) 2019-11-28
CA3029455A1 (en) 2018-01-04
AU2017289150A1 (en) 2019-01-24
BR112018077219A2 (pt) 2019-04-09

Similar Documents

Publication Publication Date Title
JP6478927B2 (ja) 消化管閉塞の予防のための材料
JP6554121B2 (ja) 気管支閉鎖剤としての自己組織化ペプチド
JP2022023249A (ja) 内視鏡的剥離術後の食道狭窄を予防するための自己集合性ペプチドマトリックス
JP6545727B2 (ja) 肺大気胞を治療するための自発組織化ペプチド
FR2756493A1 (fr) Dispositif d'administration locale de formulations solides ou semi-solides
JP2020011125A (ja) 肺の漏出を治療するための自発組織化ペプチド
JP2016515113A5 (enExample)
Lim et al. Current status and advances in esophageal drug delivery technology: influence of physiological, pathophysiological and pharmaceutical factors
JPWO2013133413A1 (ja) 粘膜隆起剤
US20160030628A1 (en) Treatment for bile leakage
JP2019508175A (ja) 膵液瘻の閉鎖
JP7049557B2 (ja) 生物組織の癒着の予防
ES2717326T3 (es) Composición tópica para el tratamiento de lesiones en mucosas
US10961274B2 (en) Self-assembling peptides comprising non-ionic polar amino acids for anti-adhesion

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200622

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200622

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210528

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210827

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20211027

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20211207

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20220304

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220421